Report Detail
Global (United States, European Union and China) Neuroleptics Market Research Report 2019-2025
- RnM3675404 |
- 16 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Neuroleptics are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.
In 2019, the market size of Neuroleptics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Neuroleptics.
This report studies the global market size of Neuroleptics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Neuroleptics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Johnson & Johnson
Pfizer
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
GSK
Allergan
...
Market Segment by Product Type
First Generation
Second Generation
Third Generation
Market Segment by Application
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Neuroleptics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Neuroleptics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Neuroleptics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Neuroleptics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 First Generation
- 1.3.3 Second Generation
- 1.3.4 Third Generation
- 1.4 Market Segment by Application
- 1.4.1 Global Neuroleptics Market Share by Application (2019-2025)
- 1.4.2 Schizophrenia
- 1.4.3 Bipolar Disorder
- 1.4.4 Unipolar Depression
- 1.4.5 Dementia
- 1.4.6 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Neuroleptics Market Size
- 2.1.1 Global Neuroleptics Revenue 2014-2025
- 2.1.2 Global Neuroleptics Sales 2014-2025
- 2.2 Neuroleptics Growth Rate by Regions
- 2.2.1 Global Neuroleptics Sales by Regions 2014-2019
- 2.2.2 Global Neuroleptics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Neuroleptics Sales by Manufacturers
- 3.1.1 Neuroleptics Sales by Manufacturers 2014-2019
- 3.1.2 Neuroleptics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Neuroleptics Revenue by Manufacturers (2014-2019)
- 3.2.2 Neuroleptics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Neuroleptics Market Concentration Ratio (CR5 and HHI)
- 3.3 Neuroleptics Price by Manufacturers
- 3.4 Key Manufacturers Neuroleptics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Neuroleptics Market
- 3.6 Key Manufacturers Neuroleptics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 First Generation Sales and Revenue (2014-2019)
- 4.1.2 Second Generation Sales and Revenue (2014-2019)
- 4.1.3 Third Generation Sales and Revenue (2014-2019)
- 4.2 Global Neuroleptics Sales Market Share by Type
- 4.3 Global Neuroleptics Revenue Market Share by Type
- 4.4 Neuroleptics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Neuroleptics Sales by Application
6 United States
- 6.1 United States Neuroleptics Breakdown Data by Company
- 6.2 United States Neuroleptics Breakdown Data by Type
- 6.3 United States Neuroleptics Breakdown Data by Application
7 European Union
- 7.1 European Union Neuroleptics Breakdown Data by Company
- 7.2 European Union Neuroleptics Breakdown Data by Type
- 7.3 European Union Neuroleptics Breakdown Data by Application
8 China
- 8.1 China Neuroleptics Breakdown Data by Company
- 8.2 China Neuroleptics Breakdown Data by Type
- 8.3 China Neuroleptics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Neuroleptics Breakdown Data by Company
- 9.2 Rest of World Neuroleptics Breakdown Data by Type
- 9.3 Rest of World Neuroleptics Breakdown Data by Application
- 9.4 Rest of World Neuroleptics Breakdown Data by Countries
- 9.4.1 Rest of World Neuroleptics Sales by Countries
- 9.4.2 Rest of World Neuroleptics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Johnson & Johnson
- 10.1.1 Johnson & Johnson Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Neuroleptics
- 10.1.4 Neuroleptics Product Introduction
- 10.1.5 Johnson & Johnson Recent Development
- 10.2 Pfizer
- 10.2.1 Pfizer Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Neuroleptics
- 10.2.4 Neuroleptics Product Introduction
- 10.2.5 Pfizer Recent Development
- 10.3 Eli Lilly
- 10.3.1 Eli Lilly Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Neuroleptics
- 10.3.4 Neuroleptics Product Introduction
- 10.3.5 Eli Lilly Recent Development
- 10.4 Bristol-Myers Squibb
- 10.4.1 Bristol-Myers Squibb Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Neuroleptics
- 10.4.4 Neuroleptics Product Introduction
- 10.4.5 Bristol-Myers Squibb Recent Development
- 10.5 AstraZeneca
- 10.5.1 AstraZeneca Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Neuroleptics
- 10.5.4 Neuroleptics Product Introduction
- 10.5.5 AstraZeneca Recent Development
- 10.6 GSK
- 10.6.1 GSK Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Neuroleptics
- 10.6.4 Neuroleptics Product Introduction
- 10.6.5 GSK Recent Development
- 10.7 Allergan
- 10.7.1 Allergan Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Neuroleptics
- 10.7.4 Neuroleptics Product Introduction
- 10.7.5 Allergan Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Neuroleptics Sales Channels
- 11.2.2 Neuroleptics Distributors
- 11.3 Neuroleptics Customers
12 Market Forecast
- 12.1 Global Neuroleptics Sales and Revenue Forecast 2019-2025
- 12.2 Global Neuroleptics Sales Forecast by Type
- 12.3 Global Neuroleptics Sales Forecast by Application
- 12.4 Neuroleptics Forecast by Regions
- 12.4.1 Global Neuroleptics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Neuroleptics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Neuroleptics. Industry analysis & Market Report on Neuroleptics is a syndicated market report, published as Global (United States, European Union and China) Neuroleptics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Neuroleptics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
